Merck Makes Further Inroads into Biologicals
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 2 (Table of Contents)
Published: 12 Feb-2009
DOI: 10.3833/pdr.v2009.i2.85 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Merck acquires Insmed’s portfolio of protein-based drugs and manufacturing facilities for US$130 M in a bid to accelerate its entry into the lucrative biosimilars market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS